AAAAAA
Results:
1-20
|
Results: 20
Authors:
Koivisto, P
Bergstrom, SK
Markides, KE
Citation: P. Koivisto et al., Determination of the free concentration of ropivacaine in plasma by packedcapillary liquid chromatography: A comparison of ultrafiltration and microdialysis as sample preparation methods, J MICROCOL, 13(5), 2001, pp. 197-201
Authors:
Matikainen, MP
Pukkala, E
Schleutker, J
Tammela, TLJ
Koivisto, P
Sankila, R
Kallioniemi, OP
Citation: Mp. Matikainen et al., Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland, CANC CAUSE, 12(3), 2001, pp. 223-230
Authors:
Yli-Harja, O
Koivisto, P
Bangham, JA
Cawley, G
Harvey, R
Shmulevich, I
Citation: O. Yli-harja et al., Simplified implementation of the recursive median sieve, SIGNAL PROC, 81(7), 2001, pp. 1565-1570
Authors:
Koivisto, P
Yli-Harja, O
Niemisto, A
Shmulevich, I
Citation: P. Koivisto et al., Breakdown probabilities of recursive stack filters, SIGNAL PROC, 81(1), 2001, pp. 227-231
Authors:
Srivastava, M
Bubendorf, L
Srikantan, V
Fossom, L
Nolan, L
Glasman, M
Leighton, X
Fehrle, W
Pittaluga, S
Raffeld, M
Koivisto, P
Willi, N
Gasser, TC
Kononen, J
Sauter, G
Kallioniemi, OP
Srivastava, S
Pollard, HB
Citation: M. Srivastava et al., ANX7, a candidate tumor suppressor gene for prostate cancer, P NAS US, 98(8), 2001, pp. 4575-4580
Authors:
Koivisto, P
Peltonen, K
Citation: P. Koivisto et K. Peltonen, N7-guanine adducts of the epoxy metabolites of 1,3-butadiene in mice lung, CHEM-BIO IN, 135, 2001, pp. 363-372
Authors:
Saramaki, O
Willi, N
Bratt, O
Gasser, TC
Koivisto, P
Nupponen, NN
Bubendorf, L
Visakorpi, T
Citation: O. Saramaki et al., Amplification of EIF3S3 gene is associated with advanced stage in prostatecancer, AM J PATH, 159(6), 2001, pp. 2089-2094
Authors:
Schleutker, J
Matikainen, M
Smith, J
Koivisto, P
Baffoe-Bonnie, A
Kainu, T
Gillanders, E
Sankila, R
Pukkala, E
Carpten, J
Stephan, D
Tammela, T
Brownstein, M
Bailey-Wilson, J
Trent, J
Kallioniemi, OP
Citation: J. Schleutker et al., A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: Frequent HPCX linkage in families with late-onset disease, CLIN CANC R, 6(12), 2000, pp. 4810-4815
Authors:
Kainu, T
Juo, SHH
Desper, R
Schaffer, AA
Gillanders, E
Rozenblum, E
Freas-Lutz, D
Weaver, D
Stephan, D
Bailey-Wilson, J
Kallioniemi, OP
Tirkkonen, M
Syrjakoski, K
Kuukasjarvi, T
Koivisto, P
Karhu, R
Holli, K
Arason, A
Johannesdottir, G
Bergthorsson, JT
Johannsdottir, H
Egilsson, V
Barkardottir, RB
Johannsson, O
Haraldsson, K
Sandberg, T
Holmberg, E
Gronberg, H
Olsson, H
Borg, A
Vehmanen, P
Eerola, H
Heikkila, P
Pyrhonen, S
Nevanlinna, H
Citation: T. Kainu et al., Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus, P NAS US, 97(17), 2000, pp. 9603-9608
Authors:
Palmberg, C
Koivisto, P
Kakkola, L
Tammela, TLJ
Kallioniemi, OP
Visakorpi, T
Citation: C. Palmberg et al., Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer, J UROL, 164(6), 2000, pp. 1992-1995
Authors:
Bowen, C
Bubendorf, L
Voeller, HJ
Slack, R
Willi, N
Sauter, G
Gasser, TC
Koivisto, P
Lack, EE
Kononen, J
Kallioniemi, OP
Gelmann, EP
Citation: C. Bowen et al., Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression, CANCER RES, 60(21), 2000, pp. 6111-6115
Authors:
Bubendorf, L
Kolmer, M
Kononen, J
Koivisto, P
Mousses, S
Chen, YD
Mahlamaki, E
Schraml, P
Moch, H
Willi, N
Elkahloun, AG
Pretlow, TG
Gasser, TC
Mihatsch, MJ
Sauter, G
Kallioniemi, OP
Citation: L. Bubendorf et al., Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and issue microarrays, J NAT CANC, 91(20), 1999, pp. 1758-1764
Authors:
Swart, R
Koivisto, P
Markides, KE
Citation: R. Swart et al., Capillary solid-phase extraction-tandem mass spectrometry for fast quantification of free concentrations of tolterodine and two metabolites in ultrafiltered plasma samples, J CHROMAT B, 736(1-2), 1999, pp. 247-253
Authors:
Palmberg, C
Koivisto, P
Visakorpi, T
Tammela, TLJ
Citation: C. Palmberg et al., PSA decline is an independent prognostic marker in hormonally treated prostate cancer, EUR UROL, 36(3), 1999, pp. 191-196
Authors:
Koivisto, P
Kilpelainen, I
Rasanen, I
Adler, ID
Pacchierotti, F
Peltonen, K
Citation: P. Koivisto et al., Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: a high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure, CARCINOGENE, 20(7), 1999, pp. 1253-1259
Authors:
Rajaniemi, H
Rasanen, I
Koivisto, P
Peltonen, K
Hemminki, K
Citation: H. Rajaniemi et al., Identification of the major tamoxifen-DNA adducts in rat liver by mass spectroscopy, CARCINOGENE, 20(2), 1999, pp. 305-309
Authors:
Bubendorf, L
Kononen, J
Koivisto, P
Schraml, P
Moch, H
Gasser, TC
Willi, N
Mihatsch, MJ
Sauter, G
Kallioniemi, OP
Citation: L. Bubendorf et al., Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays, CANCER RES, 59(4), 1999, pp. 803-806
Authors:
Swart, R
Koivisto, P
Markides, KE
Citation: R. Swart et al., Column switching in capillary liquid chromatography tandem mass spectrometry for the quantitation of pg/ml concentrations of the free basic drug tolterodine and its active 5-hydroxymethyl metabolite in microliter volumes of plasma, J CHROMAT A, 828(1-2), 1998, pp. 209-218
Authors:
Koivisto, P
Adler, ID
Pacchierotti, F
Peltonen, K
Citation: P. Koivisto et al., Regio- and stereospecific DNA adduct formation in mouse lung at N-6 and N7position of adenine and guanine after 1,3-butadiene inhalation exposure, BIOMARKERS, 3(6), 1998, pp. 385-397
Authors:
Koivisto, P
Citation: P. Koivisto, Comparison of measured and FDTD calculated distortions of antenna radiation patterns due to nearby boards, J ELECTROM, 12(12), 1998, pp. 1679-1699
Risultati:
1-20
|